Next Article in Journal
The Role of AMPK in the Regulation of Skeletal Muscle Size, Hypertrophy, and Regeneration
Next Article in Special Issue
Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP+ Neurotoxicity
Previous Article in Journal
Comparative Genome-Wide Survey of Single Nucleotide Variation Uncovers the Genetic Diversity and Potential Biomedical Applications among Six Macaca Species
Previous Article in Special Issue
Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 19
Issue 10
10.3390/ijms19103124
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke

by
Anne Lembach
1,†,
Anna Stahr
1,†,
Amira A. H. Ali
1,
Marc Ingenwerth
1,2 and
Charlotte Von Gall
1,*
1
Institute of Anatomy II, Medical Faculty, Heinrich-Heine-University, Merowinger Platz 1A, 40225 Düsseldorf, Germany
2
Institute for Pathology, University Hospital Essen, Hufelandstraße 55, 45147 Essen, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2018, 19(10), 3124; https://doi.org/10.3390/ijms19103124
Submission received: 4 September 2018 / Revised: 1 October 2018 / Accepted: 3 October 2018 / Published: 11 October 2018
(This article belongs to the Special Issue Neuroprotective Strategies 2018)
Browse Figures
Versions Notes

Abstract

:
Stroke is a leading cause of disability and death worldwide. There is increasing evidence that occurrence of ischemic stroke is affected by circadian system and sex. However, little is known about the effect of these factors on structural recovery after ischemic stroke. Therefore, we studied infarction in cerebral neocortex of male and female mice with deletion of the clock gene Bmal1 (Bmal1−/−) after focal ischemia induced by photothrombosis (PT). The infarct core size was significantly smaller 14 days (d) as compared to seven days after PT, consistent with structural recovery during the sub-acute phase. However, when sexes were analyzed separately 14 days after PT, infarct core was significantly larger in wild-type (Bmal1+/+) female as compared to male Bmal1+/+ mice, and in female Bmal1+/+, as compared to female Bmal1−/− mice. Volumes of reactive astrogliosis and densely packed microglia closely mirrored the size of infarct core in respective groups. Estradiol levels were significantly higher in female Bmal1−/− as compared to Bmal1+/+ mice. Our data suggests a sex-dependent effect and an interaction between sex and genotype on infarct size, the recruitment of astrocytes and microglia, and a relationship of these cells with structural recovery probably due to positive effects of estradiol during the subacute phase.

1. Introduction

Ischemic stroke is one of the major causes of disability and death worldwide. Risk factors include aging, high blood pressure, metabolic disturbances, as well as an “unhealthy” life style, such as smoking and obesity. While age-specific stroke rates are higher in men, women have relatively more stroke events because of their longer life expectancy [1]. In addition women are less likely to show excellent recovery [2]. There is a time-of-day dependent variation in the vulnerability to ischemia and in the occurrence of ischemic events [3,4], and shift work has been shown to be a risk factor for cardiovascular diseases in women [5]. Additionally, mice show a sex-dependent difference in stroke vulnerability [6] and a time-of-day dependent variation in neural damage after stroke [7]. Moreover, there is a sex-difference in the impact of shift work schedules on infarct volume and sensorimotor outcome in mice [8], suggesting an interaction between the two risk factors of female sex and chronodisruption. The circadian system drives rhythms in behavior, physiology, metabolism, and cognitive functions. The master circadian oscillator is located within the hypothalamic suprachiasmatic nucleus (SCN). The SCN orchestrates peripheral circadian oscillators in many tissues and organs. On the cellular level, the molecular clockwork is composed of interacting positive and negative transcriptional/translational feedback loops of clock genes [9,10]. This molecular clockwork drives rhythmic gene expression and thus rhythmic cell and organ function. The transcription factor BMAL1 (brain and muscle ARNT-like protein) is an essential component of the molecular clockwork. Mice with a targeted deletion of the Bmal1 gene (Bmal1−/−) do not only show a complete loss of circadian rhythms, but also a severely reduced life span with various symptoms of premature aging as well as cognitive deficits [11,12,13,14,15,16]. We could show earlier that Bmal1-deficiency leads to an accelerated age-dependent decline in adult neurogenesis [15].
In this study, we analyzed the effects of Bmal1-deficiency and biological sex on mouse cerebral cortex infarction in response to focal cortical ischemia induced by photothrombosis (PT). The peri-infarct area surrounding the infarct core plays an important role in recovery and is an important therapeutic target during the sub-acute phase of ischemia. In mice, behavioral recovery is most prominent between six and 14 days (d) after PT [17]. Thus, we did not only analyze the infarct core but also volumes of reactive astrogliosis and densely packed microglia in the peri-infarct area seven days (d) and 14 days after PT.
Here, we demonstrate an interaction between circadian clock and sex on structural recovery in the peri-infarct area during the subacute phase of ischemia. Our findings point to an acceleration of structural recovery in the time interval between seven and 14 days after ischemic stroke by chronodisruption in female mice.

2. Results

2.1. Effect of Bmal1-Deficiency and Biological Sex on Infarct Core Volume

The volume of infarct core (Figure 1a–h) was significantly smaller in both Bmal1+/+ mice and Bmal1−/− mice 14 days (d), as compared to seven days after PT, when both sexes were taken together (Figure 1i). There was no significant difference in the infarct core volume between Bmal1+/+ mice and Bmal1−/− mice seven days or 14 days after PT. In Bmal1+/+ mice, an infarct core volume of ≤0.1 mm3 could be observed in two from 10 (20%) mice seven days after PT and in six from 10 mice (60%) 14 days after PT (Figure 1i). In Bmal1−/− mice, an infarct core volume of ≤ 0.1 mm3 could be observed in six from nine (66%) mice seven days after PT and in nine from nine mice (100%) 14 days after PT. However, when the sexes were analyzed separately, the infarct core volume was significantly smaller in female Bmal1−/− mice 14 days compared to seven days after PT (Figure 1j). In Bmal1+/+ mice, infarct core volume was significantly larger in females as compared to males 14 days after PT (Figure 1j). All male Bmal1+/+ mice and none of the female Bmal1+/+ mice showed a regression of infarct core to a volume ≤0.1 mm3 14 days after PT (Figure 1j). In Bmal1−/− mice, a significantly larger infarct core volume was observed in females in comparison to males 7 days after PT (Figure 1j). However 14 days after PT, female Bmal1−/− mice showed a significantly smaller infarct core volume as compared to female Bmal1+/+ mice (Figure 1j).

2.2. Effect of Bmal1-Deficiency and Biological Sex on Volumes of Reactive Astrogliosis and Densely Packed Microglia in the Peri-Infarct Area

The volume of reactive astrogliosis in the peri-infarct area (Figure 1a–h), as determined by the dense GFAP-immunoreactive area surrounding the infarct core, was not significantly different between Bmal1+/+ mice and Bmal1−/− mice, when both sexes were analyzed together (Figure 1k). However, when the sexes were analyzed separately, the volume of reactive astrogliosis in peri-infarct area was only significantly smaller in female Bmal1−/− mice 14 days compared to 7 days after PT (Figure 1l). In both Bmal1+/+ mice and Bmal1−/− mice, the volume of reactive astrogliosis in the peri-infarct area was significantly larger in females as in males seven days after PT (Figure 1l). Consistent with the volume of infarct core, the volume of reactive astrogliosis in peri-infarct area was significantly smaller in female Bmal1−/− mice as compared to female Bmal1+/+ mice 14 days after PT (Figure 1l).
The volume of densely packed microglia, as determined by the dense IBA-immunoreactive area (Figure 2a–h), was significantly smaller in Bmal1+/+ mice 14 days as compared to seven days after PT, when both sexes were taken together (Figure 2i). However, when the sexes were analysed separately, the volume of densely packed microglia was significantly smaller in female Bmal1−/− mice 14 days after PT, as compared to seven days (Figure 2j). In Bmal1+/+ mice, the volume of densely packed microglia was significantly larger in females as compared to males 14 days after PT (Figure 2j). In Bmal1−/− mice, the volume of densely packed microglia following ischemia was significantly larger in females as compared to males seven days after PT (Figure 2j). Consistent with the volumes of the infarct core and the reactive astrogliosis in the peri-infarct area, the volume of densely packed microglia was significantly smaller in female Bmal1−/− mice as compared to female Bmal1+/+ mice 14 days after PT (Figure 2j).

2.3. Analyses of Newborn Cells in the Infarct Region

For quantification of the total number of newborn cells in a defined region of the peri-infarct area, the number of BrdU+ cells was counted (Figure 3a–h). When both sexes were taken together, the number of newborn cells was significantly smaller in Bmal1+/+ and Bmal1−/− mice 14 days compared to seven days after PT, and significantly smaller in Bmal1−/− mice as compared to Bmal1+/+ mice 7 days after PT (Figure 3i). This reduction was, however, not observed when the animals were analyzed separately by gender (Figure 3j).
To further characterize the newborn cells, co-localization of BrdU with GFAP was analyzed as a measure for newborn astrocytes, and co-localization of BrdU with IBA was analyzed as a measure for newborn microglia.
The number of newborn astrocytes was significantly smaller in Bmal1+/+ mice 14 days as compared to seven days after PT and significantly smaller in Bmal1−/− mice compared to Bmal1+/+ mice seven days after PT, when both sexes were taken together (Figure 4a–i). This closely reflects the results on the total number of newborn cells (Figure 3j). After the separation of sexes, no significant difference between male and female animals was observed (Figure 4j).
The number of newborn microglia was significantly smaller in both genotypes 14 days when compared to seven days after PT (Figure 5a–h), when both sexes were taken together (Figure 5i). After separation of sexes, there was no significant difference among the 8 groups (Figure 5j).
Double staining for BrdU and the neuronal marker NeuN confirmed the absence of newly proliferated mature neurons (data not shown), which is consistent with several studies following focal ischemia in rats and mice [17,18].

2.4. Analysis of GnRH-Immunoreaction and Estradiol Levels

As only in females, differences in the volume of infarct core, glial scar, microglial activation, and number of newborn cells in the per-infarct area between Bmal1+/+ and Bmal1−/− mice were observed, we tested GnRH-immunoreaction and plasma estradiol levels. While the number of GnRH-immunoreactive cells did not differ between female Bmal1+/+ and Bmal1−/− mice (Figure 6a,b) the amount of GnRH-immunoreactive fibers was significantly higher in female Bmal1−/− compared to Bmal1+/+ mice in both the preoptic area (Figure 6a,c) and the medio-basal hypothalamus (Figure 6d,e). Moreover, the plasma estradiol levels were significantly higher in female Bmal1−/− compared to female Bmal1+/+ mice (Figure 6f).

3. Discussion

In this study we analyzed the effect of Bmal1-deficiency, as a model for circadian rhythms disruption, and biological sex on the volume of infarct core, reactive astrogliosis, and densely packed microglia in peri-infarct area during the subacute stage after focal ischemic stroke induced by photothrombosis (PT).
In both Bmal1+/+ and Bmal1−/− mice, volume of infarct core was significantly reduced 14 days (d) compared to seven days after PT. This is consistent with a time-dependent decrease in the infarct size during the late acute stage (3–6 d) and the sub-acute stage (7–31 d) in rodents such as rats [19,20,21] or mice [17,22] after focal ischemic stroke induced by PT. A similar time-dependent regression in infarct size can be observed in human patients after ischemic stroke by means of serial follow-up diffusion-weighted magnetic resonance imaging [23,24,25]. When both sexes were taken together, there was no significant difference in the infarct core volume between Bmal1+/+ and Bmal1−/− mice 7 days or 14 days after PT. Recent findings showed a pro-thrombotic phenotype in Bmal1-deficient mice associated with an increased platelet aggregation [26] and a reduced stress response [27]. While these vascular factors could be considered to play a modulatory role in stroke outcome in Bmal1-deficient mice, Bmal1-deficiency per se does, according to our results, not affect regression of the infarct core.
However, when the sexes were analyzed separately, we found significant differences between males and females as well as between females of both genotypes even within this small sample size. This suggests effects of sex and genotype on infarct core volume. Surprisingly, 14 days after PT, the volume of infarct core was significantly larger in female Bmal1+/+ mice, as compared to Bmal1−/− mice. This was unexpected, as acutely after stroke (one and three days), the infarct core is larger in male mice, as compared to female mice [28]. This indicates that biological sex does not only affect the vulnerability but also the dynamic of recovery after stroke.
Importantly, Earnest et al. showed an interaction between circadian rhythm disruption and biological sex to modulate pathological effects of stroke [8]. They showed, that in rats kept under a shift work like light/dark 12h:12h (LD) cycle, males but not females showed a significant increase in mortality after middle cerebral artery occlusion (MCAo). Five days after MCAo, the surviving female rats kept under shift-work like conditions showed a significantly higher infarct volume and sensorimotor deficits relative to female rats kept under non-shift work like conditions [8]. Furthermore, ambient light induced an evident sex-dependent response of body temperature and blood pressure only in females, indicating a crucial sex-related difference in the circadian regulation of cardiovascular functions [29]. In our study, there was no significant difference in infarct core volume between female Bmal1+/+ and Bmal1−/− mice sacrificed seven days after PT. However, volumes of infarct core, astrocytes and densely packed microglia in the peri-infarct area were significantly smaller in female Bmal1−/− mice as compared to female Bmal1+/+ sacrificed 14 days after PT. This shows that in females, circadian rhythm disruption as a consequence of shift work-like schedule has a negative effect of infarct progression during the acute stage [30], whereas circadian rhythm disruption as a consequence of Bmal1-deficieny has a positive effect on infarct progression during the sub-acute stage (this study). Female rats under shift-work like conditions showed persistent estrus associated with increased estradiol levels and decreased IGF-1 levels [8]. This is consistent with changes in morphology of GnRH-neurons and increased estradiol levels observed in our study as well as disturbed estrus cycle in Bmal1-deficient mice [31,32]. Furthermore, previous findings point to an interaction between the Bmal1 gene and the estrogen receptor 1 gene (ESR1), encoding the estrogen receptor (ER), which has shown to mediate the neuroprotective functions of estrogen [33]. There is ample evidence for the neuroprotective effect of estrogen in ischemia [28,34,35,36]. There are, however, other factors beyond estrogen that have been shown to modulate sex differences in circadian timing systems [37,38] and could consequently have influenced the findings of this work. These factors should, consequently, also be taken into consideration for further research.
Following ischemic or traumatic brain injury, astrocytes exhibit multiple changes, and are known to become reactive [39,40,41]. In this reactive state, the so-called reactive astrogliosis, astrocytes are characterized by an excessive expression of GFAP and depending on the extent of damage eventually form a glial scar surrounding the central ischemic core [20,42,43]. Moreover, focal ischemic stroke induces a context-specific immune reaction. Microglia are the resident immune cells of the CNS and undergo activation after pathological events. There is evidence that microglia provide essential protective functions after focal ischemia [44,45]. Therefore, we examined the volume of reactive astrogliosis and microglia surrounding the infarct core. When both sexes were analyzed together, we did not find a significant difference in the volume of the astrocytes in peri-infarct area between seven days and 14 days after PT in both genotypes. This is consistent with the dynamic of GFAP-immunopositive cells in the vicinity of the infarct showing a high increase during the acute phase (two–four days after PT) and no significant change during the sub-acute phase (six–14 days after PT) [17]. Thus, in the sub-acute phase the time-dependent decline in infarct core is not strongly correlated with a time-dependent decline in the volume of reactive astrogliosis in the peri-infarct area. However, when the sexes were analyzed separately, we found a significantly larger volume of reactive astrogliosis in peri-infarct area in females as compared to males seven days after PT in both genotypes. This suggests a sex-dependent effect on the formation of the glial scar during the sub-acute phase. The volume of densely packed microglia was significantly smaller 14 days, as compared to seven days after PT in Bmal1+/+ mice. This is consistent with a decrease in the infarct core volume. Moreover, when the sexes were analyzed separately, we found the same differences between sexes and genotypes in the volume of densely packed microglia as in the volume of the infarct core. This suggests, that during the sub-acute stage the effects of sex and genotype on infarct volume and densely packed microglia activation are closely related. Following ischemic injury, astrocytes and microglia have been shown to undergo a variety of changes, such as hypertrophy and proliferation [43]. The total number of proliferating cells, proliferating astrocytes, and proliferating microglia in the peri-infarct area was smaller seven days compared to 14 days after PT in Bmal1+/+ mice. Thus, there is a time-dependent decrease of cell, astrocyte and microglia-proliferation during the sub-acute phase. However, there was no sex-dependent difference in the total number of proliferating cells, proliferating astrocytes or proliferating microglia. Therefore, the sex-dependent differences in infarct core volume are presumably not a consequence of newly born astrocytes or microglia, but rather due to the activation of resident astrocytes and microglia of the peri-infarct area.
In summary, our data show a sex-dependent difference and a sex-dependent effect of Bmal1-deficiency on infarct core volume during the sub-acute phase after focal cortical ischemia. These effects do not seem to be dependent on proliferation, but activation or recruitment of astrocytes and microglia in the peri-infarct area. In conclusion, our results support the hypothesis of an interaction between biological sex and chronodisruption on structural recovery after stroke.

4. Material and Methods

4.1. Experimental Animals

All animal procedures were performed in accordance with animal welfare regulations and experimental protocols were approved by the local government authority LANUV (North Rhine-Westphalia State Agency for Nature, Environment and Consumer Protection; Germany; Reference numbers: 84-02.04.2012.A380, initial approval date: 26 June 2013, approval date of amendments: 25 February 2014, 7 October 2014; 84-02.04.2014.A314, approval date: 9 December 2014). Heterozygous mice with a targeted deletion of Bmal1 (Bmal1+/−) were obtained from Jackson Laboratories (B6.129-Arntltm1Bra/J) and kept for breeding at the local animal facility of University of Düsseldorf to obtain Bmal1−/− and Bmal1+/+ littermates. PCR was used to determine the genotype [11]. Mice were housed in standard cages, with 12 h light/12h darkness with free access to food and water. Male and female Bmal1+/+ and Bmal1−/− littermates (8–12 weeks old) were used. At this age, the Bmal1−/− mice do not show global astrogliosis [13]. This was confirmed by morphological analysis of GFAP-immunoreactive astrocytes contralateral to the focal cortical ischemia.

4.2. Induction of Cortical Stroke by Photothrombosis

For induction of focal cortical ischemia, photothrombosis (PT) was applied. Adult Bmal1+/+ and Bmal1−/− mice were anesthetized by 2–2.5% isoflurane in mixture of nitrous oxide and oxygen. After stereotactic fixation of the head (Stereotakte, Digital Stereotaxic Instrument, 51730D, Stoelting Co., Wood Dale, IL, USA), the scalp was shaved and opened. The cold light source (1.5 mm diameter, 2500 Lux, KL1500 LCD, Schott, Mainz, Germany) was placed 2.0 mm dorsal and 2.5 mm lateral from bregma. After the injection of the photosensitive dye Rose Bengal (43 mg/kg body weight dissolved in 0.9% saline, Sigma Aldrich, St. Louis, MO, USA) into the tail vein, the cold light source was applied for 15 min. The activation of the photosensitive Rose Bengal leads to the release of free oxygen radicals in the area of light exposure, which results in a local endothelial damage with subsequent aggregation of platelets. Consequently, the local disruption of blood supply leads to an irreversible damage on the tissue [22,46]. For analgesic treatment, carprofen (Rimadyl®, 4 mg/kg body weight dissolved in 0.9% saline) was injected subcutaneously during surgery as well as for two consecutive days after surgery. The mice were sacrificed 7 days or 14 days after PT, as at 7 days after PT the astrocytes in the region surrounding the infarct core are densely packed and start to form a glial scar [17,19,22] and 14 days after PT, the activation of microglia in the lesion is fully developed [20]. In human patients, the time frame from 7 days to 6 month after stroke is considered as the subacute stage [30].

4.3. BrdU Assay for Proliferating Cells

For quantification of newly born cells after induction of focal cortical infarct by PT, the proliferation marker 5-Brom-2′-desoxyuridin (BrdU (Roche, Basel, Switzerland) 100 mg/kg body weight dissolved in 0.9% saline) was injected intraperitoneally on three consecutive days. One group of mice was injected with BrdU from the third to the sixth post-ischemic day and the mice were sacrificed one day after the last injection (7 days). The second group was injected with BrdU from the eighth to thirteenth post-ischemic day and sacrificed on day 14 after PT (14 d).

4.4. Perfusion and Tissue Preparation

Mice were deeply anaesthetized using ketamine: xylazine (100 mg: 10 mg/kg body weight) and transcardially perfused with 0.9% NaCl followed by 4% paraformaldehyde in phosphate buffered saline (PBS). Brains were removed and post fixed in 4% paraformaldehyde (in PBS) for 24 h and cryoprotected in 20% sucrose in PBS for another 24 h. Neocortex with infarct area was sectioned coronally (30 µm thickness) by using a cryomicrotome (Reichert-Jung, New York, NY, USA) in 12 parallel series. Each parallel series was used for immunohistochemistry or immunofluorescence with a different antibody.

4.5. Immunohistochemistry and Analyses of Volumes of Infarct Core, Reactive Astrogliosis in Peri-Infarct Area and Densely Packed Microglia

Free-floating sections were washed in washing butter (0.2% Triton-X 100 in PBS) and then incubated with 0.24% H2O2 in PBS for 30 min at room temperature. After further washing, sections were incubated with the primary antibody against the astrocytic marker GFAP (1:1500, Dako Agilent Technologies, Santa Clara, CA, USA, Z0334) or the microglial marker IBA1 (1:500, Wako Industries, Osaka, Japan, 019-19741) overnight at 4 °C, followed by goat anti-rabbit IgG (1:500, Vector Laboratories, Burlingame, CA, USA, ZA0520) for 2 h at room temperature. After further washing, sections were incubated with Vectastain Elite ABC Kit (Vector Laboratories) for 1 h followed by incubation in 3.3’-diaminobenzidine (Sigma-Aldrich) in the presence of 0.3% hydrogen peroxide for 10 min. Sections were washed with PBS/0.2% Triton-X 100, mounted on microscope slides. Slides were air-dried and cover-slipped with Entellan (Merck Millipore, Danvers, MA, USA).
Infarct core corresponds to the central ischemic core and peri-infarct area was defined as the area of reactive astrogliosis and microglia surrounding the infarct core [47,48]. Volumes of infarct core, reactive astrogliosis and densely packed microglia in the peri-infarct area were analyzed 7 days and 14 days after PT in male and female Bmal1+/+ mice (7d ♂ Bmal1+/+ n = 4; 7d ♀ Bmal1+/+ n = 6; 14d ♂ Bmal1+/+ n = 5; 14d ♀ Bmal1+/+ n = 5) and Bmal1−/− mice (7d ♂ Bmal1−/− n = 4; 7d ♀ Bmal1−/− n = 6; 14d ♂ Bmal1−/− n = 5; 14d ♀ Bmal1−/− n = 4). Image analysis was performed by an observer blind to the experimental condition. Volume of infarct core and reactive astrogliosis in peri-infarct area were determined by GFAP-immunoreaction (IR) (Figure A1a–c in Appendix A). Volume of densely packed microglia was determined by IBA1-IR (Figure A1d). ImageJ software (NIH, Bethesda, MD, USA) was used to measure the respective areas in 2–4 sections per slide. The volumes of the infarct core, reactive astrogliosis in peri-infarct area and densely packed microglia were calculated for each mouse from respective areas, the number of analyzed sections and the section thickness.

4.6. Immunofluorescence and Analysis of Newly Born Cells in the Per-Infarct Area

Antigen retrieval was performed by treatment of free-floating sections with 2 N HCl (10 min, 37 °C) followed by 0.1 M borid acid (10 min). After washing sections were incubated with rat anti-BrdU-antibody (1:500, AbD Serotec, Raleigh, NC, USA, OBT0030CX) and rabbit anti-GFAP (1:1000, Dako Agilent Technologies, Santa Clara, USA, Z0334), rabbit anti-IBA1 (1:500, Wako Industries, Osaka, Japan, 019-19741), the neuron marker NeuN (Merck Milipore, Billerica, MA, USA ABN78) overnight at 4 °C. Following further washing, sections were incubated with a mixture of Alexa-Fluor 488 goat anti-rat (1:500, Life Technologies, NC, USA, A-11006) and Alexa-Fluor 568 goat anti-rabbit (1:500, Life Technologies, A-11036) for 3 h at room temperature and darkness. Slices were washed and mounted on slides. Slides were air-dried and cover-slipped with Mowiol.
Newborn cells were analyzed in a defined region within the peri-infarct area (Figure A1e,f) in male and female Bmal1+/+ mice (n = 3; 7d ♂ Bmal1+/+ n = 3; 7d ♀ Bmal1+/+ n = 3; 14d ♂ Bmal1+/+ n = 3; 14d ♀ Bmal1+/+ n = 3) and Bmal1−/− mice (n = 3; 7d ♂ Bmal1−/− n = 3; 7d ♀ Bmal1−/− n = 3; 14d ♂ Bmal1−/− n = 3; 14d ♀ Bmal1−/− n = 3). An observer blind to the experimental condition performed image analysis. Immunofluorescent cells were counted in z-stacks (2 µm) of microphotographs obtained by confocal laser scanning microscopy (LSM 510 Meta, Carl Zeiss, Oberkochen, Germany). The total number of BrdU-positive (BrdU+) cells was counted and the number of double-labelled cells for BrdU and GFAP (BrdU+/GFAP+-cells) as well as BrdU and IBA1 (BrdU+/IBA1+-cells) were determined.

4.7. Analysis of Gonadotropin Releasing Hormone (GnRH) Positive Neurons and Fibers

Female 10–12 weeks old Bmal1+/+ (n = 4) and Bmal1−/− (n = 4) mice were used. Brains, including hypothalamus, were sectioned coronally (30 µm thickness) by using a cryomicrotome (Reichert-Jung) in 6 parallel series. One of these series was stained with immunohistochemistry as described above using a rabbit polyclonal anti GnRH (1:4000, Immunostar, Hudson, WI, USA). Image acquisition was performed using bright field mode on a Keyence BZ 900E microscope (Keyence, Osaka, Japan) with settings kept constant through image acquisition. An observer blind to the genotype performed image analysis. GnRH-immunoreactive neurons were counted manually in the preoptic area (POA) (0.62–0.38 mm rostral from bregma, according to Franklin and Paxinos mouse brain atlas). GnRH-immunoreactive fibers were analyzed in POA and at their projection to the median eminence (ME) using ImageJ software. Data was expressed as percentage of area covered with GnRH fibers relative to the total area.

4.8. Estradiol Assay

For the estradiol assay in female Bmal1+/+ (n = 19) and Bmal1−/− mice (n = 14), blood was drawn from the right atrium, collected in EDTA sample tubes and centrifuged at 4 °C for 15 min at 1400× g. From the supernatant/plasma 25 µL were subjected to estradiol-ELISA (SE-120049, Sigma Aldrich) according to the manufacturer’s protocol. Plates were read at 450 nm in a plate reader (Multiskan FC, ThermoScientific, Waltham, MA, USA). Assay sensitivity ranged from 10 to 1000 pg/mL.

4.9. Statistical Analysis

Data was statistically analyzed using GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA, USA). Data are presented as mean. Due to special hypotheses concerning the difference between two groups, respectively, pairwise comparisons with Mann-Whitney-U Test were performed. Values of p < 0.05 were considered significantly different.

Author Contributions

Conceptualization, A.L., and A.S.; Methodology, A.L., A.S., M.I., and A.A.H.A.; Data analysis, A.L., A.S., A.A.H.A. and M.I.; Writing-Original Draft Preparation, A.L., A.S., A.A.H.A.; Writing-Review and Editing, A.L., A.S., A.A.H.A., C.v.G.; Visualization, A.L., A.A.H.A., C.v.G.; Supervision, C.v.G.; Project Administration C.v.G.

Acknowledgments

We thank H. Bellert, R. Fassbender, A. Hallenberger and U. Lammersen for excellent technical support and H.W. Korf as well as F. Tundo-Lavalle for helpful discussions.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Ijms 19 03124 g0a1 550
Figure A1. Definition of infarct region, infarct core, peri-infarct area, area of densely packed microglia and part of the peri-infarct area for quantification of newborn cells. (a) Infarct region including the infarct core and peri-infarct area; (b) infarct core; (c) reactive astrogliosis in peri-infarct area was determined by GFAP-immunoreaction and indicated by freehand drawing in a representative section. (d) Area of densely packed microglia was determined by IBA1-immunoreaction and indicated by freehand drawing in a representative section. Scale bar = 300 µm. (e) Part of the peri-infarct area for quantification of newborn cells is indicated by the box in a representative section. Scale bar = 300µm, (f) Boxed region from (e) at higher magnification. Scale bars = 50 µm.
Figure A1. Definition of infarct region, infarct core, peri-infarct area, area of densely packed microglia and part of the peri-infarct area for quantification of newborn cells. (a) Infarct region including the infarct core and peri-infarct area; (b) infarct core; (c) reactive astrogliosis in peri-infarct area was determined by GFAP-immunoreaction and indicated by freehand drawing in a representative section. (d) Area of densely packed microglia was determined by IBA1-immunoreaction and indicated by freehand drawing in a representative section. Scale bar = 300 µm. (e) Part of the peri-infarct area for quantification of newborn cells is indicated by the box in a representative section. Scale bar = 300µm, (f) Boxed region from (e) at higher magnification. Scale bars = 50 µm.
Ijms 19 03124 g0a1

References

  1. Reeves, M.J.; Bushnell, C.D.; Howard, G.; Gargano, J.W.; Duncan, P.W.; Lynch, G.; Khatiwoda, A.; Lisabeth, L. Sex differences in stroke: Epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008, 7, 915–926. [Google Scholar] [CrossRef]
  2. Etherton, M.R.; Wu, O.; Cougo, P.; Giese, A.K.; Cloonan, L.; Fitzpatrick, K.M.; Kanakis, A.S.; Boulouis, G.; Karadeli, H.H.; Lauer, A.; et al. Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke. Stroke 2017, 48, 3387–3389. [Google Scholar] [CrossRef] [PubMed]
  3. Foerch, C.; Korf, H.W.; Steinmetz, H.; Sitzer, M.; Arbeitsgruppe Schlaganfall, H. Abrupt shift of the pattern of diurnal variation in stroke onset with daylight saving time transitions. Circulation 2008, 118, 284–290. [Google Scholar] [CrossRef] [PubMed]
  4. Elliott, W.J. Circadian variation in the timing of stroke onset: A meta-analysis. Stroke 1998, 29, 992–996. [Google Scholar] [CrossRef] [PubMed]
  5. Kawachi, I.; Colditz, G.A.; Stampfer, M.J.; Willett, W.C.; Manson, J.E.; Speizer, F.E.; Hennekens, C.H. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995, 92, 3178–3182. [Google Scholar] [CrossRef] [PubMed]
  6. Zhao, L.; Mulligan, M.K.; Nowak, T.S., Jr. Substrain- and sex-dependent differences in stroke vulnerability in C57BL/6 mice. J. Cereb. Blood Flow Metab. 2017. [Google Scholar] [CrossRef] [PubMed]
  7. Beker, M.C.; Caglayan, B.; Yalcin, E.; Caglayan, A.B.; Turkseven, S.; Gurel, B.; Kelestemur, T.; Sertel, E.; Sahin, Z.; Kutlu, S.; et al. Time-of-Day Dependent Neuronal Injury After Ischemic Stroke: Implication of Circadian Clock Transcriptional Factor Bmal1 and Survival Kinase AKT. Mol. Neurobiol 2018, 55, 2565–2576. [Google Scholar] [CrossRef] [PubMed]
  8. Earnest, D.J.; Neuendorff, N.; Coffman, J.; Selvamani, A.; Sohrabji, F. Sex Differences in the Impact of Shift Work Schedules on Pathological Outcomes in an Animal Model of Ischemic Stroke. Endocrinology 2016, 157, 2836–2843. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Shearman, L.P.; Sriram, S.; Weaver, D.R.; Maywood, E.S.; Chaves, I.; Zheng, B.; Kume, K.; Lee, C.C.; van der Horst, G.T.; Hastings, M.H.; et al. Interacting molecular loops in the mammalian circadian clock. Science 2000, 288, 1013–1019. [Google Scholar] [CrossRef] [PubMed]
  10. Reppert, S.M.; Weaver, D.R. Coordination of circadian timing in mammals. Nature 2002, 418, 935–941. [Google Scholar] [CrossRef] [PubMed]
  11. Bunger, M.K.; Wilsbacher, L.D.; Moran, S.M.; Clendenin, C.; Radcliffe, L.A.; Hogenesch, J.B.; Simon, M.C.; Takahashi, J.S.; Bradfield, C.A. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103, 1009–1017. [Google Scholar] [CrossRef]
  12. Kondratova, A.A.; Dubrovsky, Y.V.; Antoch, M.P.; Kondratov, R.V. Circadian clock proteins control adaptation to novel environment and memory formation. Aging 2010, 2, 285–297. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Musiek, E.S.; Lim, M.M.; Yang, G.; Bauer, A.Q.; Qi, L.; Lee, Y.; Roh, J.H.; Ortiz-Gonzalez, X.; Dearborn, J.T.; Culver, J.P.; et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J. Clin. Investig. 2013, 123, 5389–5400. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Kondratov, R.V.; Kondratova, A.A.; Gorbacheva, V.Y.; Vykhovanets, O.V.; Antoch, M.P. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev. 2006, 20, 1868–1873. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Ali, A.A.; Schwarz-Herzke, B.; Stahr, A.; Prozorovski, T.; Aktas, O.; von Gall, C. Premature aging of the hippocampal neurogenic niche in adult Bmal1-deficient mice. Aging 2015, 7, 435–449. [Google Scholar] [CrossRef] [PubMed]
  16. Chang, L.; Xiong, W.; Zhao, X.; Fan, Y.; Guo, Y.; Garcia-Barrio, M.; Zhang, J.; Jiang, Z.; Lin, J.D.; Chen, Y.E. Bmal1 in Perivascular Adipose Tissue Regulates Resting-Phase Blood Pressure Through Transcriptional Regulation of Angiotensinogen. Circulation 2018, 138, 67–79. [Google Scholar] [CrossRef] [PubMed]
  17. Li, H.; Zhang, N.; Lin, H.Y.; Yu, Y.; Cai, Q.Y.; Ma, L.; Ding, S. Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice. BMC Neurosci. 2014, 15, 58. [Google Scholar] [CrossRef] [PubMed]
  18. Haupt, C.; Witte, O.W.; Frahm, C. Up-regulation of Connexin43 in the glial scar following photothrombotic ischemic injury. Mol. Cell. Neurosci. 2007, 35, 89–99. [Google Scholar] [CrossRef] [PubMed]
  19. Nowicka, D.; Rogozinska, K.; Aleksy, M.; Witte, O.W.; Skangiel-Kramska, J. Spatiotemporal dynamics of astroglial and microglial responses after photothrombotic stroke in the rat brain. Acta Neurobiol. Exp. 2008, 68, 155–168. [Google Scholar]
  20. Schroeter, M.; Schiene, K.; Kraemer, M.; Hagemann, G.; Weigel, H.; Eysel, U.T.; Witte, O.W.; Stoll, G. Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp. Brain Res. 1995, 106, 1–6. [Google Scholar] [CrossRef] [PubMed]
  21. Shanina, E.V.; Redecker, C.; Reinecke, S.; Schallert, T.; Witte, O.W. Long-term effects of sequential cortical infarcts on scar size, brain volume and cognitive function. Behav. Brain Res. 2005, 158, 69–77. [Google Scholar] [CrossRef] [PubMed]
  22. Schroeter, M.; Jander, S.; Stoll, G. Non-invasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels: Characterization of inflammatory responses. J. Neurosci. Methods 2002, 117, 43–49. [Google Scholar] [CrossRef]
  23. Fitzek, S.; Fitzek, C.; Urban, P.P.; Marx, J.; Hopf, H.C.; Stoeter, P. Time course of lesion development in patients with acute brain stem infarction and correlation with NIHSS score. Eur. J. Radiol. 2001, 39, 180–185. [Google Scholar] [CrossRef]
  24. Schwamm, L.H.; Koroshetz, W.J.; Sorensen, A.G.; Wang, B.; Copen, W.A.; Budzik, R.; Rordorf, G.; Buonanno, F.S.; Schaefer, P.W.; Gonzalez, R.G. Time course of lesion development in patients with acute stroke: Serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998, 29, 2268–2276. [Google Scholar] [CrossRef] [PubMed]
  25. Lansberg, M.G.; O’Brien, M.W.; Tong, D.C.; Moseley, M.E.; Albers, G.W. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch. Neurol. 2001, 58, 613–617. [Google Scholar] [CrossRef] [PubMed]
  26. Somanath, P.R.; Podrez, E.A.; Chen, J.; Ma, Y.; Marchant, K.; Antoch, M.; Byzova, T.V. Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J. Cell. Physiol. 2011, 226, 132–140. [Google Scholar] [CrossRef] [PubMed]
  27. Curtis, A.M.; Cheng, Y.; Kapoor, S.; Reilly, D.; Price, T.S.; Fitzgerald, G.A. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc. Natl. Acad. Sci. USA 2007, 104, 3450–3455. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Manwani, B.; Bentivegna, K.; Benashski, S.E.; Venna, V.R.; Xu, Y.; Arnold, A.P.; McCullough, L.D. Sex differences in ischemic stroke sensitivity are influenced by gonadal hormones, not by sex chromosome complement. J. Cereb. Blood Flow Metab. 2015, 35, 221–229. [Google Scholar] [CrossRef] [PubMed]
  29. Gubin, D.G.; Weinert, D.; Rybina, S.V.; Danilova, L.A.; Solovieva, S.V.; Durov, A.M.; Prokopiev, N.Y.; Ushakov, P.A. Activity, sleep and ambient light have a different impact on circadian blood pressure, heart rate and body temperature rhythms. Chronobiol. Int. 2017, 34, 632–649. [Google Scholar] [CrossRef] [PubMed]
  30. Nordin, N.; Xie, S.Q.; Wunsche, B. Assessment of movement quality in robot- assisted upper limb rehabilitation after stroke: A review. J. Neuroeng. Rehabil. 2014, 11, 137. [Google Scholar] [CrossRef] [PubMed]
  31. Ratajczak, C.K.; Boehle, K.L.; Muglia, L.J. Impaired steroidogenesis and implantation failure in Bmal1-/- mice. Endocrinology 2009, 150, 1879–1885. [Google Scholar] [CrossRef] [PubMed]
  32. Boden, M.J.; Varcoe, T.J.; Voultsios, A.; Kennaway, D.J. Reproductive biology of female Bmal1 null mice. Reproduction 2010, 139, 1077–1090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Dubal, D.B.; Zhu, H.; Yu, J.; Rau, S.W.; Shughrue, P.J.; Merchenthaler, I.; Kindy, M.S.; Wise, P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 2001, 98, 1952–1957. [Google Scholar] [CrossRef] [PubMed]
  34. McCullough, L.D.; Hurn, P.D. Estrogen and ischemic neuroprotection: An integrated view. Trends Endocrinol. Metab. 2003, 14, 228–235. [Google Scholar] [CrossRef]
  35. Liu, F.; McCullough, L.D. Interactions between Age, Sex, and Hormones in Experimental Ischemic Stroke. Neurochem. Int. 2012, 61, 1255–1265. [Google Scholar] [CrossRef] [PubMed]
  36. Ritzel, R.M.; Capozzi, L.A.; McCullough, L.D. Sex, stroke, and inflammation: The potential for estrogen-mediated immunoprotection in stroke. Horm. Behav. 2013, 63, 238–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Bailey, M.; Silver, R. Sex differences in circadian timing systems: Implications for disease. Front. Neuroendocrinol. 2014, 35, 111–139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Yan, L.; Silver, R. Neuroendocrine underpinnings of sex differences in circadian timing systems. J. Steroid Biochem. Mol. Biol. 2016, 160, 118–126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Rolls, A.; Shechter, R.; Schwartz, M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10, 235–241. [Google Scholar] [CrossRef] [PubMed]
  40. Buffo, A.; Rolando, C.; Ceruti, S. Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential. Biochem. Pharmacol. 2010, 79, 77–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Parpura, V.; Heneka, M.T.; Montana, V.; Oliet, S.H.; Schousboe, A.; Haydon, P.G.; Stout, R.F., Jr.; Spray, D.C.; Reichenbach, A.; Pannicke, T.; et al. Glial cells in (patho)physiology. J. Neurochem. 2012, 121, 4–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Faulkner, J.R.; Herrmann, J.E.; Woo, M.J.; Tansey, K.E.; Doan, N.B.; Sofroniew, M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24, 2143–2155. [Google Scholar] [CrossRef] [PubMed]
  43. Sofroniew, M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32, 638–647. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Lalancette-Hebert, M.; Gowing, G.; Simard, A.; Weng, Y.C.; Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 2007, 27, 2596–2605. [Google Scholar] [CrossRef] [PubMed]
  45. Jin, W.N.; Shi, S.X.; Li, Z.; Li, M.; Wood, K.; Gonzales, R.J.; Liu, Q. Depletion of microglia exacerbates postischemic inflammation and brain injury. J. Cereb. Blood Flow Metab. 2017, 37, 2224–2236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Dietrich, W.D.; Watson, B.D.; Busto, R.; Ginsberg, M.D.; Bethea, J.R. Photochemically induced cerebral infarction. I. Early microvascular alterations. Acta Neuropathol. 1987, 72, 315–325. [Google Scholar] [CrossRef] [PubMed]
  47. Uzdensky, A.B. Photothrombotic Stroke as a Model of Ischemic Stroke. Transl. Stroke Res. 2018, 9, 437–451. [Google Scholar] [CrossRef] [PubMed]
  48. Carmichael, S.T. Rodent models of focal stroke: Size, mechanism, and purpose. NeuroRx 2005, 2, 396–409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ijms 19 03124 g001 550
Figure 1. Effect of Bmal1-deficiency and sex on infarct core and astrocytes in the peri-infarct area. Infarct core and reactive astrogliosis in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were determined by GFAP-immunoreaction (IR). (a) Bmal1+/+ male 7 days (d) after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) volume of infarct core in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 9–10 per genotype); and (j) volume of infarct core in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 4–5 per genotype and sex). (k) Volume of reactive astrogliosis in the peri-infarct area in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 9–10 per genotype); (l) Volume of reactive astrogliosis in the peri-infarct area in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 4–5 per genotype and sex). * p < 0.05, Mann Whitney-U Test. Scale bar = 300 µm.
Figure 1. Effect of Bmal1-deficiency and sex on infarct core and astrocytes in the peri-infarct area. Infarct core and reactive astrogliosis in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were determined by GFAP-immunoreaction (IR). (a) Bmal1+/+ male 7 days (d) after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) volume of infarct core in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 9–10 per genotype); and (j) volume of infarct core in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 4–5 per genotype and sex). (k) Volume of reactive astrogliosis in the peri-infarct area in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 9–10 per genotype); (l) Volume of reactive astrogliosis in the peri-infarct area in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 4–5 per genotype and sex). * p < 0.05, Mann Whitney-U Test. Scale bar = 300 µm.
Ijms 19 03124 g001
Ijms 19 03124 g002 550
Figure 2. Effect of Bmal1-deficiency and sex on volume of densely packed microglia. Microglia after focal cortical ischemia induced by photothrombosis (PT) was determined by IBA-immunoreaction (IR). (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) volume of densely packed microglia in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 9–10 per genotype); and (j) volume of densely packed microglia in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 4–5 per genotype and sex). * p < 0.05, Mann Whitney-U Test. Scale bar = 300 µm.
Figure 2. Effect of Bmal1-deficiency and sex on volume of densely packed microglia. Microglia after focal cortical ischemia induced by photothrombosis (PT) was determined by IBA-immunoreaction (IR). (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) volume of densely packed microglia in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 9–10 per genotype); and (j) volume of densely packed microglia in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 4–5 per genotype and sex). * p < 0.05, Mann Whitney-U Test. Scale bar = 300 µm.
Ijms 19 03124 g002
Ijms 19 03124 g003 550
Figure 3. Effect of Bmal1-deficiency and sex on the number of newborn cells. Newborn cells in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were analysed by BrdU-immunoreaction. (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) number of BrdU-immunopositive (+) cells within the infarct region in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 6 per genotype); and (j) number of BrdU-immunopositive (+) cells within the peri-infarct area in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 3 per genotype and sex). * p < 0.05, ** p < 0.01, Mann Whitney-U Test. Scale bar = 300 µm.
Figure 3. Effect of Bmal1-deficiency and sex on the number of newborn cells. Newborn cells in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were analysed by BrdU-immunoreaction. (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) number of BrdU-immunopositive (+) cells within the infarct region in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 6 per genotype); and (j) number of BrdU-immunopositive (+) cells within the peri-infarct area in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 3 per genotype and sex). * p < 0.05, ** p < 0.01, Mann Whitney-U Test. Scale bar = 300 µm.
Ijms 19 03124 g003
Ijms 19 03124 g004 550
Figure 4. Effect of Bmal1-deficiency and sex on the number of newborn astrocytes. Newborn astrocytes in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were examined and analyzed by double-immunoreaction of BrdU and GFAP. (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) number of BrdU-/GFAP-immunopositive (+) cells within the peri-infarct area in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 6 per genotype); and (j) number of BrdU-/GFAP-immuno-positive (+) cells within the infarct region in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 3 per genotype and sex). ** p < 0.01, Mann Whitney-U Test. Scale bar = 300 µm.
Figure 4. Effect of Bmal1-deficiency and sex on the number of newborn astrocytes. Newborn astrocytes in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were examined and analyzed by double-immunoreaction of BrdU and GFAP. (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; (i) number of BrdU-/GFAP-immunopositive (+) cells within the peri-infarct area in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 6 per genotype); and (j) number of BrdU-/GFAP-immuno-positive (+) cells within the infarct region in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 3 per genotype and sex). ** p < 0.01, Mann Whitney-U Test. Scale bar = 300 µm.
Ijms 19 03124 g004
Ijms 19 03124 g005 550
Figure 5. Effect of Bmal1-deficiency and sex on the number of newborn microglia cells. Newborn microglia cells in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were analysed by double-immunoreaction of BrdU and IBA. (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; and (i) number of BrdU-/IBA-immunopositive (+) cells within the peri-infarct area in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 6 per genotype); (j) Number of BrdU-/IBA-immunopositive (+) cells within the infarct region in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 3 per genotype and sex). ** p < 0.01, Mann Whitney-U Test. Scale bar = 300 µm.
Figure 5. Effect of Bmal1-deficiency and sex on the number of newborn microglia cells. Newborn microglia cells in the peri-infarct area after focal cortical ischemia induced by photothrombosis (PT) were analysed by double-immunoreaction of BrdU and IBA. (a) Bmal1+/+ male 7 days after PT; (b) Bmal1+/+ male 14 days after PT; (c) Bmal1−/− male 7 days after PT; (d) Bmal1−/− male 14 days after PT; (e) Bmal1+/+ female 7 days after PT; (f) Bmal1+/+ female 14 days after PT; (g) Bmal1−/− female 7 days after PT; (h) Bmal1−/− female 14 days after PT; and (i) number of BrdU-/IBA-immunopositive (+) cells within the peri-infarct area in Bmal1+/+ and Bmal1−/− mice of both sexes (n = 6 per genotype); (j) Number of BrdU-/IBA-immunopositive (+) cells within the infarct region in Bmal1+/+ and Bmal1−/− mice separated by sex (n = 3 per genotype and sex). ** p < 0.01, Mann Whitney-U Test. Scale bar = 300 µm.
Ijms 19 03124 g005
Ijms 19 03124 g006 550
Figure 6. Effect of Bmal1-deficiency on gonadotropin releasing hormone and estrogen in female mice. Gonadotropin releasing hormone (GnRH) neurons and fibers were identified by GnRH-immunoreaction (n = 4 per genotype), estrogen plasma levels were determined by ELISA (n = 14–19 per genotype). (a) GnRH-immunoreaction in the preoptic area of Bmal1+/+ female and Bmal1−/− female mice. (b) Number of GnRH-immunopositive (+) cells in the preoptic area of Bmal1+/+ female and Bmal1−/− female mice. (c) Percentage of GnRH-immunopositive (+) fibers in the preoptic area of Bmal1+/+ female and Bmal1−/− female mice. (d) GnRH-immunoreaction in the median eminence of Bmal1+/+ female and Bmal1−/− female mice. (e) Percentage of GnRH-immunopositive (+) fibers in the median eminence of Bmal1+/+ female and Bmal1−/− female mice. (f) Levels of plasma estradiol in Bmal1+/+ female and Bmal1−/− female mice. Third ventricle (TV), Median eminence (ME), * p < 0.05, Mann Whitney-U Test. Scale bars = 50 µm.
Figure 6. Effect of Bmal1-deficiency on gonadotropin releasing hormone and estrogen in female mice. Gonadotropin releasing hormone (GnRH) neurons and fibers were identified by GnRH-immunoreaction (n = 4 per genotype), estrogen plasma levels were determined by ELISA (n = 14–19 per genotype). (a) GnRH-immunoreaction in the preoptic area of Bmal1+/+ female and Bmal1−/− female mice. (b) Number of GnRH-immunopositive (+) cells in the preoptic area of Bmal1+/+ female and Bmal1−/− female mice. (c) Percentage of GnRH-immunopositive (+) fibers in the preoptic area of Bmal1+/+ female and Bmal1−/− female mice. (d) GnRH-immunoreaction in the median eminence of Bmal1+/+ female and Bmal1−/− female mice. (e) Percentage of GnRH-immunopositive (+) fibers in the median eminence of Bmal1+/+ female and Bmal1−/− female mice. (f) Levels of plasma estradiol in Bmal1+/+ female and Bmal1−/− female mice. Third ventricle (TV), Median eminence (ME), * p < 0.05, Mann Whitney-U Test. Scale bars = 50 µm.
Ijms 19 03124 g006

Share and Cite

MDPI and ACS Style

Lembach, A.; Stahr, A.; Ali, A.A.H.; Ingenwerth, M.; Von Gall, C. Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke. Int. J. Mol. Sci. 2018, 19, 3124. https://doi.org/10.3390/ijms19103124

AMA Style

Lembach A, Stahr A, Ali AAH, Ingenwerth M, Von Gall C. Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke. International Journal of Molecular Sciences. 2018; 19(10):3124. https://doi.org/10.3390/ijms19103124

Chicago/Turabian Style

Lembach, Anne, Anna Stahr, Amira A. H. Ali, Marc Ingenwerth, and Charlotte Von Gall. 2018. "Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke" International Journal of Molecular Sciences 19, no. 10: 3124. https://doi.org/10.3390/ijms19103124

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop